Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients
Status:
Completed
Trial end date:
2020-06-19
Target enrollment:
Participant gender:
Summary
Study in adult Diabetes Mellitus patients with diabetic foot ulcers and elevated HbA1c who
will receive standard wound treatment in combination with adjuvant therapy WF10 to compare
the change of HbA1c levels at baseline and after treatment.